Skip to content
  • OUR SERVICES
  • WHY ORCHESTRA
  • WHO WE ARE
    • Executive Management
    • Our Experts
    • Our Team
  • Our Clients
  • Resources
    • Radiopharma Brochure
    • Cyclotron Ebook
    • Blog
    • Press
    • Career
  • Contact
  • OUR SERVICES
  • WHY ORCHESTRA
  • WHO WE ARE
    • Executive Management
    • Our Experts
    • Our Team
  • Our Clients
  • Resources
    • Radiopharma Brochure
    • Cyclotron Ebook
    • Blog
    • Press
    • Career
  • Contact

Press

Orchestra Life Sciences Names Charles Conroy as Chief Operating Officer

August 18, 2026
Read More

Orchestra Life Sciences Named No. 203 on 2026 Inc. 5000 List

August 12, 2026
Read More

Orchestra Life Sciences Expands into Europe to Support Radiopharmaceutical Execution, Appoints Vinod Ramnandanlal as President and Managing Director

January 27, 2026
Read More

Orchestra Life Sciences Relocates Global Headquarters to Philadelphia’s Navy Yard

October 27, 2025
Read More

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell TherapyFacility Development

January 16, 2025
Read More

Orchestra Life Sciences Partners with Life Couriers to Expand Supply Chain Capabilities and Broaden Access to Critical Cancer Treatments

September 17, 2024
Read More

Orchestra Life Sciences Expands Access to Radioisotope Lead-212 (Pb-212) Through Strategic Collaboration with Precirix

July 8, 2024
Read More

Orchestra Life Sciences provides strategic support and scientific expertise to accelerate the innovation of novel treatments for cancers and rare disease.

Contact Info

  • info@orchestralifesciences.com
  • 636-268-0101
  • 16091 Swingley Ridge Road Suite 360 Chesterfield, MO 63017
  • 1200 Intrepid Ave, Ste. 105B, Philadelphia, PA 19112

Subscribe to our newsletter

Follow US

Facebook Twitter Youtube

Orchestra Life Sciences 2026